Clinical Trial Update: Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study evaluating RDC-0313 coadministered with buprenorphine in opioid-experienced healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Use Disorder

Drugs mentioned

• RDC-0313
• buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Substance-Related Disorders | Phase 1 | Status: COMPLETED